Abstract:Purpose: Recently, emerging evidences have shown that microbiome might play an important role in the pathogenesis of osteoarthritis (OA). Previously, we have proposed a two-hit model of OA pathogenesis and potentiation in which shifts of gut microbiome acted the innate immune response as one hit. Another hit results from joint damage that releases a lot of damage associated with molecular patterns (DAMPs), resulting in a synergistic activation of inflammatory pathways leading to OA. The current study was aimed to prove our two-hit hypothesis. Methods: Basic information, fecal and blood samples were collected in three different groups of people: health control, OA without metabolic syndrome (MS), OA with metabolic syndrome. Low-density lipoprotein (LDL), high-density lipoprotein (HDL), triglyceride (TG) and cholesterol (CHOL) were detected in the blood samples. 16S RNA sequencing was used to profile the composition of microbiome in fecal samples and compared in groups. Based on different types of fecal transplantation and surgical treatments, thirty-nine germ free mice were divided into following groups: 1) Group 1: transplanted with sterile water for 7 days then MLI model was induced; 2) Group 2: transplanted with fecal samples from people of health control group and sham surgery was induced; 3) Group 3: transplanted with fecal samples from people of health control group and MLI model was induced; 4) Group 4: transplanted with fecal samples from patients of OA without MS group and MLI model was induced; 5) Group 5: transplanted with fecal samples from patients of OA with MS group and MLI model was induced. Mice were sacrificed 6 weeks following surgery. All the knee joints, blood samples, small intestine and colon were collected. Customized inflammatory biomarkers panel (Milliplex®) was used to detect inflammatory biomarkers in the blood samples. Also, lipopolysaccharide (LPS) and lipopolysaccharide binding protein were also detected in the blood samples. Knee joints were processed for histology analysis and stained in Safranin O for OARSI scoring. 16S RNA sequencing was applied in fecal samples collected from both small intestine and colon for microbiome profiling and compared in groups. FISH was used to visualize the change of permeability of colonic mucosa. Data were analyzed using Kruskal-Wallis test. Spearman correlations were calculated between inflammatory biomarkers, OARSI scores and microbiome profiles. Results: Totally nineteen patients were recruited, 4 in the health control group, 7 in the OA without MS group and 8 in the OA with MS group. Significant higher BMI (p<0.001), LDL (p=0.007) and TG level (p=0.015) were founded in the OA with MS group. Significant lower HDL level was found in the OA with MS group compared to the other two groups (p=0.034). Microbiome profile showed no significant differences between three groups in terms of αdiversity. While significant differences in terms of β diversity was found (p=0.036). Histology analysis of the mice knee joints showed significant lower OARSI score in Group 1 and Group 2 compared with the other three groups (Figure 1). While Group 5 has the highest OARSI score compared with Group 3 and 4 (Figure 1). Inflammatory biomarkers analysis showed significant higher IL-1βand MCP-1 were founded in Group 5 (Figure 2). Significant lower αdiversity of microbiome was found in Group 5. While significant differences in terms of β diversity was also founded between groups. Correlations between OARSI score, biomarkers and microbiome profile showed that both Anaerostipes and Fusobacterium had significant positive correlations with inflammatory biomarkers and histological severity. Also Fusobacterium had a significant negative correlation with inflammatory biomarkers and histological severity. Conclusions: 1) Germ-free will alleviate the severity of OA in mice model; 2) IL-1βand MCP-1 might play an important role in germ-free protection; 3) Anaerostipes and Fusobacterium might be the cause of the MS associated OA. While Fusobacterium can protect people from MS associated OA. Further mechanism needs future explorations.View Large Image Figure ViewerDownload Hi-res image Download (PPT)

Impact of altering gut microbiota metabolism on osteomyelitis severity in obesity-related type 2 diabetes

Modulation of Gut Microbiota Metabolism in Obesity-Related Type 2 Diabetes Reduces Osteomyelitis Severity

Osteopontin Exacerbates High-Fat Diet-Induced Metabolic Disorders in a Microbiome-Dependent Manner

Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity

Oligofructose as an adjunct in treatment of diabetes in NOD mice

Gut Microbiota Modulates Osteoclast Glutathione Synthesis and Mitochondrial Biogenesis in Mice Subjected to Ovariectomy

Association of Antibiotic Alterations in Gut Microbiota With Decreased Osseointegration of an Intramedullary Nail in Mice With and Without Osteomyelitis

Obesity-Related Gut Microbiota Aggravates Alveolar Bone Destruction in Experimental Periodontitis through Elevation of Uric Acid

FOS/GOS attenuates high-fat diet induced bone loss via reversing microbiota dysbiosis, high intestinal permeability and systemic inflammation in mice

OSTEOARTHRITIS INDUCED BY MENISCAL/LIGAMENTOUS INJURY IS AGGRAVATED AFTER METABOLIC SYNDROME FECAL SAMPLE TRANSPLANTATION IN GERM-FREE MICE

Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice

Causal effects of gut microbiota on the risk of osteomyelitis: a Mendelian randomization study

The impact of prebiotic fructooligosaccharides on gut dysbiosis and inflammation in obesity and diabetes related kidney disease.

Obesity Prolongs the Pro-Inflammatory Response and Attenuates Bone Healing on Titanium Implants

Importance of gut microbiota in obesity

Immunometabolic capacities of nutritional fatty acids in regulation of inflammatory bone cell interaction and systemic impact of periodontal infection

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

Gut microbiota: an overlooked factor that plays a significant role in osteoporosis

Obesity-associated inflammation countered by a Mediterranean diet: the role of gut-derived metabolites

Modulation of bone remodeling by the gut microbiota: a new therapy for osteoporosis

Microbial-Based Bioactive Compounds to Alleviate Inflammation in Obesity